{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-24-000158","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2024-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.563077+00:00","generated_at":"2026-05-31T13:12:07.648625+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Clover Health Q2 2024: first GAAP net income of $7.2M, raises FY2024 guidance","bullets":["Q2 GAAP net income from continuing operations $7.2M vs. loss of $28.9M in Q2 2023; first positive quarter.","Total revenue $356.3M, up 11% YoY; Insurance revenue $349.9M, also up 11%.","Insurance MCR improved to 71.3% from 77.2% (590 bps improvement); Insurance BER improved to 76.1%.","Adjusted EBITDA $36.2M vs. $9.9M in Q2 2023.","FY2024 guidance raised: Insurance revenue $1.35B-$1.375B, Adjusted EBITDA $50M-$65M (from $10M-$30M)."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-24-000158","json":"https://secwatch.observer/filing/0001801170-24-000158.json","markdown":"https://secwatch.observer/filing/0001801170-24-000158.md","text":"https://secwatch.observer/filing/0001801170-24-000158.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000158/0001801170-24-000158-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000158/clov-20240805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:12:07.648625+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}